SEC-sourced researchBeta
INBX
Inhibrx Biosciences, Inc.
Company comparison ↗
Data passport
- CIK
- 0002007919
- Exchange
- Nasdaq
- Business activity
- — · SIC 2836
- Financial inputs
- 6/6
- Filing date
- Nov 17, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 200,000.0000 | Mar 19, 2026 |
| December 2025 | 1,300,000.0000 | Mar 19, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 1,300,000.0000 | -140,055,000.0000 | -129,794,000.0000 | 146,478,000.0000 | 138,485,000.0000 | Mar 19, 2026 |
| December 2024 | 200,000.0000 | 1,687,572,000.0000 | -194,409,000.0000 | 180,767,000.0000 | 47,183,000.0000 | Mar 19, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $1.3M | December 2025 | Mar 19, 2026 | 10-K |
| Previous period revenueRevenues | $200K | December 2024 | Mar 19, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$140.06M | December 2025 | Mar 19, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$129.79M | December 2025 | Mar 19, 2026 | 10-K |
| Total assetsAssets | $146.48M | December 2025 | Mar 19, 2026 | 10-K |
| Total liabilitiesLiabilities | $138.49M | December 2025 | Mar 19, 2026 | 10-K |
New filings
- 8-KINBX · Inhibrx Biosciences, Inc.Nov 17, 2026 · Current event
- S-3ASRINBX · Inhibrx Biosciences, Inc.Nov 13, 2026 · Other
- 10-QINBX · Inhibrx Biosciences, Inc.Nov 13, 2026 · Periodic
- 8-KINBX · Inhibrx Biosciences, Inc.Nov 13, 2026 · Current event
- SCHEDULE 13G/AINBX · Inhibrx Biosciences, Inc.Nov 13, 2026 · Other
- SCHEDULE 13G/AINBX · Inhibrx Biosciences, Inc.Oct 28, 2026 · Other
- 4INBX · Inhibrx Biosciences, Inc.Oct 14, 2026 · Other
- 8-KINBX · Inhibrx Biosciences, Inc.Sep 28, 2026 · Current event
- 4INBX · Inhibrx Biosciences, Inc.Sep 28, 2026 · Other